Cyclopentanone
- Part number
- RXSOL-60-6149-001
- Category
- Lab Chemical
- Brand
- RXSOL
Safety and SDS
Read the safety data sheet before handling. Wear suitable gloves and eye protection.
View safety data sheet
| Porduct Name | Cyclopentanone |
| Part Number | RXSOL-60-1042-025 |
Company Details:
RX MARINE INTERNATIONAL
105, A wing , BSEL , TECH PARK.
VASHI ,NEW BOMBAY 400703 INDIA
Branch : Kandla, Mumbai , Chennai, Vizag, Kolkata, UAE , OMAN , CANADA and KENYA
| Phone | +91 22 20871200 - 1400 |
| Fax | +91 22 27612100 :::AOH :0091 9821214367 |
| rxsolchemicals@gmail.com | |
| Website | www.rxmraine.com |
| Product name | Cas No | EC No | Weight | Formula |
| Cyclopentanone for synthesis | 120-92-3 | 204-435-9 | 84,12 g/mol | C5H8O |
| Signal Word | Warning |
| Hazard Statements | H226 Flammable liquid and vapor. H315 Causes skin irritation. H319 Causes serious eye irritation |
| Precautionary statements | P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P233 Keep container tightly closed. P240 Ground and bond container and receiving equipment. P241 Use explosion-proof electrical/ ventilating/ lighting/ equipment. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
| Classification of the substance or mixture | No data available |
| Supplemental Hazard Statements | No data available |
| Other hazards | This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. |
| General advice | Show this material safety data sheet to the doctor in attendance |
| If inhaled | After inhalation fresh air. |
| Eye Contact | After eye contact: rinse out with plenty of water. Remove contact lenses. |
| Swallowed | After swallowing: immediately make victim drink water (two glasses at most). Consult a physician. 4.2 Most import |
| Skin Contact | In case of skin contact Take off immediately all contaminated clothing. Rinse skin with water/ shower. Call a physician immediately |
| Inhalation | No data available |
| Ingestion | No data available |
| Most important symptoms and effects, both acute and delaye | The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11 |
| Indication of any immediate medical attention and special treatment needed | No data available |
| Flammability | No data available |
| Suitable extinguishing media | Water Foam Carbon dioxide (CO2) Dry powder |
| Unsuitable extinguishing media | For this substance/mixture no limitations of extinguishing agents are given. |
| Special hazards arising from the substance or mixture | Carbon oxides Combustible. Vapors are heavier than air and may spread along floors. Forms explosive mixtures with air at elevated temperatures. Development of hazardous combustion gases or vapours possible in the event of fire |
| Further information | Remove container from danger zone and cool with water. Prevent fire extinguishing water from contaminating surface water or the ground water system. |
|
Hazardous combustion products |
No data available |
| Advice for firefighters | Stay in danger area only with self-contained breathing apparatus. Prevent skin contact by keeping a safe distance or by wearing suitable protective clothing. |
| Protective Equipment | No data available |
| Specific Hazards Arising from the Chemical | No data available |
| Personal precautions, protective equipment and emergency procedures | Advice for non-emergency personnel: Avoid inhalation of dusts. Evacuate the danger area, observe emergency procedures, consult an expert. For personal protection see section 8. |
| Spillage | No data available |
| Personal Protection | No data available |
| Enviromental Precaution | Do not let product enter drains. Risk of explosion. |
|
Methods and materials for containment and cleaning |
Cover drains. Collect, bind, and pump off spills. Observe possible material restrictions (see sections 7 and 10). Take up dry. Dispose of properly. Clean up affected area. Avoid generation of dusts. |
| Reference to other sections | For disposal see section 13. |
| Advice on protection against fire and explosion | Keep away from open flames, hot surfaces and sources of ignition.Take precautionary measures against static discharge. |
| Incompatible materials | No data available |
| Hygiene measures | Immediately change contaminated clothing. Apply preventive skin protection. Wash hands and face after working with substance. For precautions see section 2.2. |
| Advice on safe handling | For precautions see section 2.2. |
| Conditions for safe storage including any incompatibilities |
No data available |
| Storage conditions | Keep container tightly closed in a dry and well-ventilated place. Keep away from heat and sources of ignition. Recommended storage temperature see product label. |
| Storage class | Storage class (TRGS 510) 3 Flammable liquids |
| Specific end use(s) | Apart from the uses mentioned in section 1.2 no other specific uses are stipulated |
| Advice on general occupational hygiene | No data available |
| Exposure controls | Personal protective equipment |
| Engineering Control | No data available |
| Eye/face protection | Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). Safety glasses |
| Body Protection | Flame retardant antistatic protective clothing. |
| Skin protection | This recommendation applies only to the product stated in the safety data sheet, supplied by us and for the designated use. When dissolving in or mixing with other substances and under conditions deviating from those stated in EN 16523-1 please contact the supplier of CE-approved gloves (e.g. KCL GmbH, D-36124 Eichenzell, Internet: www.kcl.de). Full contact Material: butyl-rubber Minimum layer thickness: 0,7 mm Break through time: 480 min Material tested:Butoject® (KCL 898) This recommendation applies only to the product stated in the safety data sheet, supplied by us and for the designated use. When dissolving in or mixing with other substances and under conditions deviating from those stated in EN 16523-1 please contact the supplier of CE-approved gloves (e.g. KCL GmbH, D-36124 Eichenzell, Internet: www.kcl.de). Splash contact Material: Nitrile rubber Minimum layer thickness: 0,4 mm Break through time: 120 min Material tested:Camatril® (KCL 730 / Aldrich Z677442, Size M) |
| Respiratory protection |
Recommended Filter type Filter A (acc. to DIN 3181) for vapours of organic compounds The entrepeneur has to ensure that maintenance, cleaning and testing of respiratory protective devices are carried out according to the instructions of the producer. These measures have to be properly documented.
|
| Other Protection Measure | No data available |
| Physical state | Liquid |
| Colour | Colorless |
| Odour | Characteristic |
| Odor Threshold | No data available |
| pH | No data available |
| Melting Point | -51 °C |
| Boiling Point | 127 - 131 °C at 1.013 hPa |
| Flash Point | 30 °C - closed cup |
| Evaporation Rate | No data available |
| Flammability (solid, gas) | No data available |
| Explosive limits | Upper explosion limit10,8 %(V) Lower explosion limit 1,6 %(V) |
| Upper/lower flammability or explosive limits | No data available |
| Autoignition temperature | 430 °C at 1.025 hPa |
| Decomposition temperature | No data available |
| Vapour pressure | No data available |
| Viscosity | Kinematic 1,32 mm2/s at 25 °C - OECD Test Guideline 114 |
| Density | 0,951 g/cm3 at 20 °C |
| Relative Density | No data available |
| Specific Gravity | No data available |
| Partition coefficient | Log Pow 0,7 at 25 °C - Bioaccumulation is not expected. |
| Explosive properties | No data available |
| Solubility | 301 g/l at 20 °C - OECD Test Guideline 105- completely soluble |
| Ignition temperature | No data available |
| Particle characteristics | No data available |
| Reactivity | Vapor/air-mixtures are explosive at intense warming. |
| Chemical stability | The product is chemically stable under standard ambient conditions (room temperature) |
| Possibilityof hazardous reactions | Exothermic reaction with Oxidizing agents polymerisation initiators Strong bases acids Risk of explosion with Nitric acid hydrogen peroxide hydrazine and derivatives hydroxylamine Violent reactions possible with: Strong oxidizing agents |
| Conditions to avoid | Heating. |
| Incompatible materials |
No data available
|
| Hazardous decomposition products | In the event of fire: see section 5 |
| Acute toxicity | LD50 Oral - Rat - male and female - > 2.000 mg/kg (OECD Test Guideline 401) LC50 Inhalation - Rat - male - 4 h - > 19,5 mg/l - vapor(OECD Test Guideline 403) LD50 Dermal - Rat - male and female - > 2.000 mg/kg (OECD Test Guideline 402) |
| Skin corrosion/irritation | Skin - Rabbit Irritating to skin. - 4 h (OECD Test Guideline 404) Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2) |
| Serious eye damage/irritation | Eyes - Rabbit Irritating to eyes. (OECD Test Guideline 405)Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2) |
| Respiratory or skin sensitization | Maximization Test - Guinea pignegative (OECD Test Guideline 406) |
| Carcinogenicity | No data available |
| Germ cell mutagenicity | Test Type Ames test Test system Escherichia coli/Salmonella typhimurium Metabolic activation: with and without metabolic activation Method: OECD Test Guideline 471 Result: negative Test Type: Chromosome aberration test in vitro Test system: Human lymphocytes Metabolic activation: with and without metabolic activation Method: OECD Test Guideline 473 Result: negative Test Type: In vitro mammalian cell gene mutation test Test system: mouse lymphoma cells Metabolic activation with and without metabolic activation Method: OECD Test Guideline 476 |
| Reproductive toxicity | No data available |
| Specific target organ toxicity - single exposure |
No data available
|
| Additional Information | The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Repeated dose toxicity - Rat - male and female - Oral - 25 Weeks - NOAEL (No observed adverse effect level) - 723 mg/kg - LOAEL (Lowest observed adverse effect level) - 1.000 mg/kg Remarks: (ECHA) To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated. Systemic effects: After absorption: Dizziness Drowsiness Convulsions Damage to: Liver Kidney Other dangerous properties can not be excluded. Handle in accordance with good industrial hygiene and safety practice. |
| Persistence and degradability | Biodegradability aerobic - Exposure time 28 d Result: > 99 % - Readily biodegradable. (OECD Test Guideline 301F) |
| Toxicity to fish | Semi-static test LC50 - Oncorhynchus mykiss (rainbow trout) - > 100 mg/l - 96 h (OECD Test Guideline 203) |
| Toxicity to daphnia and other aquatic invertebrates | Static test EC50 - Daphnia magna (Water flea) - > 100 mg/l - 48 h (OECD Test Guideline 202) |
| Toxicity | No data available |
| Toxicity to bacteria | Static test EC50 - activated sludge - > 1.000 mg/l - 3 h (OECD Test Guideline 209) |
| Toxicity to algae | Static test ErC50 - Desmodesmus subspicatus (green algae) - > 100 mg/l - 72 h (OECD Test Guideline 20 |
| Products Biodegradation | No data available |
| Mobility in soil | No data availalble |
| Results of PBT and vPvB assessment | This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. |
| Endocrine disrupting properties | The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher |
| Other adverse effects | When discharged properly, no impairments in the function of adapted biological wastewater treatment plants are to be expected. Discharge into the environment must be avoided. |
| Product | No data available |
| Contaminated packaging | No data available |
| Waste treatment Method | No data available |
| UN number | ADR/RID:2245 | IMDG:2245 |
IATA:2245 |
| UN proper shipping name | ADR/RID:CYCLOPENTANONE | IMDG:CYCLOPENTANONE | IATA:CYCLOPENTANONE |
| Transport hazard class(es) | ADR/RID:3 | IMDG:3 | IATA:3 |
| Packaging group | ADR/RID:lll | IMDG:lll | IATA:lll |
| Environmental hazards | ADR/RID:No | IMDG:No | IATA:No |
| Special precautions for user | Tunnel restriction code (D/E) | ||
| Further information | No data available |
| Safety, health and environmental regulations/legislation specific for the substance or mixture | This material safety data sheet complies with the requirements of Regulation (EC) No. 1907/2006. |
| Other regulations | Take note of Dir 94/33/EC on the protection of young people at work. |
| Chemical Safety Assessment | A Chemical Safety Assessment was not carried out for this substance. |
| Other Information |
The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and weassume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no event shall be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if Rx Marine International has been advised of the possibility of such damages. DISCLAIMER OF LIABILITY :The information in this SDS was obtained from sources which we believe are reliable. However, the information is provided without any warranty, express or implied, regarding its correctness. The conditions or methods of handling, storage, use or disposal of the product are beyond our control and may be beyond our knowledge. For this and other reasons, we do not assume responsibility and expressly disclaim liability for loss, damage or expense arising out of or in any way connected with the handling, storage, use or disposal of the product. This MSDS was prepared and is to be used only for this product. If the product is used as a component in another product, this MSDS information may not be applicable. |
